A correction in the shares of the provider of Covid-19 tests appears to be over and a new uptrend is underway.
The shares are expensive. An investment in this name is a bet on a recovering economy in a post-pandemic world.
I would probably rather play this name from the short side, but the risk must be contained.
Upside price momentum has slowed.
This does not look like the time to gamble on a rally.
We have gone from banning former players for shaking hands and smiling for pictures to inviting sports gambling right into the venues that house the events themselves.
The charts and indicators of DKNG are looking a little risky for longs.
The long side of DKS is attractive even at these heights.
The charts show a buy signal, and now is a good time to get into NKE.
What has happened to the charts?